Israel's Medigus lands FDA win for new MUSE acid reflux treatment

Medigus wins FDA clearance for the next generation of its minimally invasive MUSE system for treating acid reflux through the mouth.

Israel-based Medigus (TLV:MDGS) won FDA clearance for the next generation of its MUSE technology, a minimally invasive technology for performing surgeries to treat acid reflux disease.
Medigus Ltd.News Well, Regulatory/Clearance, 510(k), Endovascular, Food & Drug Administration (FDA), Minimally Invasive Surgery, Surgicalread more

Source: Mass Device - March 25, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news